QuidelOrtho Corporation (QDEL) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
QDEL Revenue Growth
Revenue Breakdown (FY 2023)
QDEL's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
By Geography
QDEL Revenue Analysis (2014–2025)
As of May 8, 2026, QuidelOrtho Corporation (QDEL) generated trailing twelve-month (TTM) revenue of $2.66 billion, reflecting significant decline in growth of -10.5% year-over-year. The most recent quarter (Q1 2026) recorded $619.8 million in revenue, down 14.3% sequentially.
Looking at the longer-term picture, QDEL's 5-year compound annual growth rate (CAGR) stands at +10.4%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $3.27 billion in 2022.
Revenue diversification analysis shows QDEL's business is primarily driven by Other (100%). With over half of revenue concentrated in Other, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HOLX (+2.2% YoY), BIO (+1.9% YoY), and NEOG (-3.7% YoY), QDEL has underperformed the peer group in terms of revenue growth. Compare QDEL vs HOLX →
QDEL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| QDELCurrent | $2.7B | -10.5% | +10.4% | -33.7% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% | |
 BIO | $2.6B | +1.9% | +0.3% | 10.5% | |
 NEOG | $895M | -3.7% | +16.4% | 1.1% | |
 IDXX | $4.3B | +13.1% | +9.7% | 31.6% | |
 ALGN | $4.0B | +2.9% | +10.3% | 15.3% |
QDEL Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.73B | -1.9% | $1.27B | 46.7% | $-919,200,000 | -33.7% |
| 2024 | $2.78B | -7.2% | $1.29B | 46.2% | $-1,960,900,000 | -70.5% |
| 2023 | $3.00B | -8.2% | $1.50B | 49.9% | $139.1M | 4.6% |
| 2022 | $3.27B | +92.3% | $1.94B | 59.3% | $843.7M | 25.8% |
| 2021 | $1.70B | +2.2% | $1.28B | 75.3% | $906.0M | 53.3% |
| 2020 | $1.66B | +210.7% | $1.35B | 81.2% | $1.06B | 63.8% |
| 2019 | $534.9M | +2.4% | $320.8M | 60.0% | $92.7M | 17.3% |
| 2018 | $522.3M | +88.0% | $315.7M | 60.4% | $95.9M | 18.4% |
| 2017 | $277.7M | +45.0% | $156.1M | 56.2% | $9.6M | 3.4% |
| 2016 | $191.6M | -2.3% | $118.2M | 61.7% | $-4,439,000 | -2.3% |
See QDEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs QDEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare QDEL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonQDEL — Frequently Asked Questions
Quick answers to the most common questions about buying QDEL stock.
Is QDEL's revenue growth accelerating or slowing?
QDEL revenue declined -10.5% year-over-year, contrasting with the 5-year CAGR of +10.4%. TTM revenue fell to $2.7B. This reverses the prior growth trend.
What is QDEL's long-term revenue growth rate?
QuidelOrtho Corporation's 5-year revenue CAGR of +10.4% reflects the variable expansion pattern. Current YoY growth of -10.5% is below this long-term average.
How is QDEL's revenue distributed by segment?
QDEL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.